We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+20.88%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$6.82B
AUM Growth
+$4.38B
Cap. Flow
+$3.89B
Cap. Flow %
57.09%
Top 10 Hldgs %
14.47%
Holding
2,138
New
1,069
Increased
445
Reduced
159
Closed
459

Sector Composition

Rank Sector Weight
1 Technology 12.95%
2 Consumer Discretionary 9.59%
3 Financials 9.25%
4 Healthcare 8.35%
5 Industrials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPFH
1551
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$77K ﹤0.01%
+11,198
New +$78.3K
INFN
1552
DELISTED
Infinera Corporation Common Stock
INFN
$76K ﹤0.01%
+12,840
New +$70.3K
OTIC
1553
DELISTED
Otonomy, Inc.
OTIC
$75K ﹤0.01%
+20,612
New +$53.7K
CLSD
1554
DELISTED
Clearside Biomedical
CLSD
$74K ﹤0.01%
+2,617
New +$77.1K
BHR
1555
Braemar Hotels & Resorts
BHR
$153M
$72K ﹤0.01%
+25,316
New +$73.5K
RRD
1556
DELISTED
RR Donnelley & Sons Co.
RRD
$71K ﹤0.01%
+59,776
New +$72.8K
LPCN icon
1557
Lipocine
LPCN
$17.1M
$70K ﹤0.01%
+3,252
New +$42.1K
TWI icon
1558
Titan International
TWI
$516M
$70K ﹤0.01%
+48,125
New +$64.7K
EMWP
1559
DELISTED
Eros Media World PLC
EMWP
$70K ﹤0.01%
1,108
+536
+94% +$30.2K
BNED icon
1560
Barnes & Noble Education
BNED
$412M
$69K ﹤0.01%
+430
New +$69.8K
HIMX
1561
Himax Technologies
HIMX
$2.2B
$69K ﹤0.01%
+16,739
New +$54.1K
SCYX icon
1562
SCYNEXIS
SCYX
$37M
$69K ﹤0.01%
+1,144
New +$77.6K
TTI icon
1563
TETRA Technologies
TTI
$1.23B
$69K ﹤0.01%
+128,675
New +$50.8K
YCBD icon
1564
cbdMD
YCBD
$5.65M
$68K ﹤0.01%
+99
New +$44.4K
FPRX
1565
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$68K ﹤0.01%
+11,203
New +$46.1K
VRDN icon
1566
Viridian Therapeutics
VRDN
$2.13B
$67K ﹤0.01%
+4,000
New +$45.4K
CRIS icon
1567
Curis
CRIS
$9.53M
$65K ﹤0.01%
+135
New +$49.8K
OGI
1568
Organigram Holdings
OGI
$132M
$63K ﹤0.01%
+10,150
New +$68.4K
ADMS
1569
DELISTED
Adamas Pharmaceuticals
ADMS
$63K ﹤0.01%
+24,609
New +$72.3K
AHT
1570
Ashford Hospitality Trust
AHT
$21M
$62K ﹤0.01%
+86
New +$66.6K
COCP icon
1571
Cocrystal Pharma
COCP
$12.4M
$62K ﹤0.01%
+3,378
New +$41.4K
FTK icon
1572
Flotek Industries
FTK
$935M
$62K ﹤0.01%
+8,559
New +$49K
MBRX icon
1573
Moleculin Biotech
MBRX
$15M
$62K ﹤0.01%
+29
New +$68.8K
YELL
1574
DELISTED
Yellow Corporation Common Stock
YELL
$62K ﹤0.01%
+33,512
New +$54.6K
VIVS
1575
VivoSim Labs
VIVS
$1.46M
$61K ﹤0.01%
+465
New +$56.7K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2020 Portfolio in Review

As of Q2 2020, Qube Research & Technologies (QRT) held 2,138 positions worth $6.82B, up 180% from $2.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Qube Research & Technologies (QRT) deployed $3.89B of net new capital in Q2 2020, opening 1,069 new positions and adding to 445 existing holdings. Its largest new stake was Vanguard Mortgage-Backed Securities ETF: 878,345 shares worth $47.8M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 8.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street Blackstone Senior Loan ETF, an estimated $24.1M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2020 buy was Vanguard Mortgage-Backed Securities ETF: 878,345 shares worth $47.8M.
  • Qube Research & Technologies (QRT) added most to iShares MBS ETF in Q2 2020, an estimated $138M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2020 reduction was State Street Blackstone Senior Loan ETF, cutting an estimated $24.1M.
  • Qube Research & Technologies (QRT) fully exited State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q2 2020, selling an estimated $17.6M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 14% of its $6.82B portfolio in Q2 2020.
  • Qube Research & Technologies (QRT) opened 1,069 new positions and closed 459 in Q2 2020.
  • Qube Research & Technologies (QRT)'s portfolio value rose 180% quarter-over-quarter to $6.82B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2020, filed 14 Aug 2020.